{"id":"W2571097605","doi":"10.1016/j.jtho.2016.11.514","title":"MA16.11 CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC: Pooled Data from Two Phase II Trials","year":2017,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Osimertinib; Medicine; Internal medicine; Oncology; T790M; Clinical trial; Population; Target lesion; Cancer; Epidermal growth factor receptor; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"grok","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"opus","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004752666,0.001914893,0.005662555,0.000670477,0.0002954381,0.001520109,0.0008054847,0.001004608,0.002008227],"category_scores_gemma":[0.003313201,0.000678506,0.006487652,0.001094977,0.0008477584,0.001454807,0.0005476353,0.002755477,0.0004217873],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00138541,"about_ca_system_score_gemma":0.001021483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001313911,"about_ca_topic_score_gemma":0.005992922,"domain_scores_codex":[0.9984338,0.0008005974,0.0001669041,0.0002536474,0.0001642635,0.0001808892],"domain_scores_gemma":[0.9981738,0.0006499463,0.0005943409,0.0001577023,0.0001736071,0.0002505924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6087579,0.002373802,0.02652062,0.008542377,0.1177363,0.0002162445,0.0002128227,0.008671803,0.01297887,0.0003337,0.006744066,0.2069116],"study_design_scores_gemma":[0.5071748,0.157979,0.1428605,0.001615564,0.159253,0.00118507,0.0004138257,0.003813936,0.005802489,0.001631813,0.01796355,0.0003065355],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9070147,0.08245259,0.001130697,0.001174819,0.0005868691,0.0007883643,0.002739737,0.0001051694,0.004007034],"genre_scores_gemma":[0.9742838,0.0185579,0.0005982505,0.0009111359,0.0003418324,0.0004959806,0.003160252,0.00004608189,0.001604803],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005662555,"threshold_uncertainty_score":0,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05776611874330057,"score_gpt":0.5222276652436241,"score_spread":0.4644615465003235,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}